On 25 September 2018 Immuno Valley will celebrate its 10th Anniversary of connecting international business and academia in human and animal health research. During the Annual Conference in Utrecht, CSO at Bunyavax and virologist at Wageningen Bioveterinary Research prof. dr. Jeroen Kortekaas will give a session on vaccines and emerging infectious diseases.
Bunyavax for fast vaccine development
Biotech company BunyaVax focuses on the development of vaccines based on a new vaccine technology developed by Wageningen Bioveterinary Research. Through the platform a vaccine can be developed within a few months after the emergence of pathogens (infectious agents). This can be very valuable in the event of a threatening epidemic.